$BSVN

Travis Thomas L sold $312K of BSVN

Travis Thomas L (President & CEO) sold 6,500 shares of Bank7 Corp. (BSVN) at $48.01 ($0.31M total) on 2026-07-22.

Original reporting
SEC EDGAR · Travis Thomas L
Published Jul 23, 2026, 1:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 23, 2026, 1:08 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BSVN
Neutral
high confidence
Mentioned
$BSVN
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BSVNNeutralLow
01

Why it matters

This provides a fresh datapoint on CEO selling activity, which can influence short-term sentiment but does not change the company’s fundamentals based on the text provided.

02

Market read

Traders may monitor insider activity as a sentiment input, but the filing alone does not imply new earnings, guidance, or regulatory developments.

03

What to watch

No 10b5-1 plan is cited, but the article also lacks context on prior sales, total holdings trend, tax events, or whether the sale was part of a broader planned schedule.

Relevance 4/10Novelty 5/10Timing: today’s SEC Form 4 filing (filed 2026-07-23) for a 2026-07-22 sale

Background

The article is an SEC Form 4 insider transaction disclosure for Bank7 Corp. (BSVN).

Company-level read

Ticker impact

$BSVNNeutralHigh confidence
Context

Travis Thomas L, Bank7 Corp. CEO, sold 6,500 shares on 2026-07-22 at $48.0104, totaling $312,067.60, per Form 4.

Expected impact

Likely limited near-term price impact; any effect should be small and sentiment-driven.

Evidence & confidence

The filing is a disclosed Form 4 transaction with modest size relative to typical market caps, and it provides no new operational, financial, or regulatory information.

Market effects

No direct sector read-across; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

The sale could be for diversification or liquidity needs and does not necessarily signal reduced confidence, especially without any accompanying negative company news.

Key entities

  • Bank7 Corp.

    Subject of the Form 4 insider sale by its President and CEO.

  • Travis Thomas L

    President and CEO who sold 6,500 shares on 2026-07-22.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BSVNMed

Piper Sandler raises Bank7 stock price target on strong growth

Piper Sandler raised its price target for Bank7 Corp. (BSVN) to $69.00, citing strong Q3 results with 2.24% return on assets and 16.4% return on tangible common equity. The stock is near its 52-week high, up 38% year-to-date. Piper Sandler also increased its EPS estimates for 2026 and 2027, anticipating growth from the Century Bank acquisition. Bank7 reported Q3 earnings of $1.06 per share, beating estimates, but missed on revenue.

$BSVNMed

Bank7 (BSVN) Q3 2026 Earnings Call Transcript

Bank7 (BSVN) reported Q3 2026 earnings, highlighting strong deposit growth and an upcoming merger with Century in New Mexico. The merger is expected to be neutral to their net interest margin (NIM) but will provide cheaper funding. Bank7 plans to maintain its loan growth trajectory and deploy excess liquidity methodically. Century's loan portfolio will be integrated similarly to Bank7's existing strategy.

$BSVNHighAI 8/10

Bank7 Q3 2026 slides: earnings beat forecast as Century merger nears

Bank7 Corp (BSVN) reported Q3 2026 earnings of $1.06 per share, beating estimates, with revenue at $23.37M, slightly below forecasts. Stock rose 2.02% in premarket trading. The bank saw 22.3% net income growth and announced a $137M acquisition of Century Financial, expected to close November 1, 2026, adding $1.2B in deposits. Management expects EPS accretion of over 25% from the deal.

$BSVNMed

Bank7: Q3 Earnings Presentation

Bank7 reported Q3 2026 earnings with total assets of $2.01B, net income of $10.2M, and diluted EPS of $1.06. Key metrics include a 22.3% increase in net income and a 21.8% rise in EPS. The bank announced an acquisition of Century Financial for $137M, expected to close November 1, 2026, with projected EPS accretion of 25%.